Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28595423 | 0.85 | SMN1; SMN2 (0.38) | SMN1; SMN2NPC1RAB9ASOAT1DRD4 | |
| SCHEMBL10144993 | 0.74 | NPC1 (0.43) | SMN1; SMN2NPC1RAB9A | |
| SCHEMBL19923130 | 0.73 | NPC1 (0.42) | SMN1; SMN2NPC1RAB9A | |
| SCHEMBL10106364 | 0.71 | NPC1 (0.49) | SMN1; SMN2NPC1RAB9A | |
| SCHEMBL7053663 | 0.69 | NPC1 (0.39) | NPC1RAB9ADRD4 | |
| SCHEMBL641310 | 0.69 | SMN1; SMN2 (0.52) | SMN1; SMN2NPC1RAB9ASOAT1 | |
| SCHEMBL10330558 | 0.69 | RAB9A (0.46) | SMN1; SMN2NPC1RAB9A | |
| SCHEMBL16978298 | 0.67 | APP (0.43) | DRD4 | |
| SCHEMBL767623 | 0.67 | LARS1 (0.33) | SMN1; SMN2NPC1RAB9A | |
| SCHEMBL23143212 | 0.66 | L3MBTL1 (0.39) | SMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113105360-A | Multi-modal probe FN and preparation method and application thereof | 暨南大学附属第一医院(广州华侨医院) | 2021-07-13 | — | — | CN | claimed |
| CN-113105360-A | Multi-modal probe FN and preparation method and application thereof | 暨南大学附属第一医院(广州华侨医院) | 2021-07-13 | — | — | CN | disclosed |